Wuhan ADICON Medical Laboratory Co., Ltd.

ADICON Medical Laboratory Center Co., Ltd. was established in 2004 and has set up 24 medical laboratories across China, making it one of the top three in China's third-party medical testing industry. The company adopts the advanced management system of independent laboratories in Europe and America, introduces international high-end quality standards, and conducts extensive cooperation and exchanges with global medical testing peers, providing medical testing, clinical trials, scientific research services, health management, and pathology consultation services.
At present, ADICON has 5 major central laboratories and R&D centers in clinical, pathology, reproductive genetics, genetic testing, and clinical trials, with more than 20 specialized clinical laboratories under its umbrella, providing more than 2,700 testing items, cooperating with nearly 14,000 medical institutions nationwide, with an average daily testing volume of 250,000 cases.
ADICON regards quality as its lifeline. Since its establishment, a total of 17 laboratories have successively obtained ISO15189 accreditation. During the pandemic, a total of 20 laboratories passed the national external quality assessment for novel coronavirus nucleic acid testing. It has also obtained US CAP certification, UK CEQAS quality system assessment, and domestic CMA qualification accreditation, etc.